Gable Davida Marie
Known title: VP, Controller & Global SSCIK: 0001894566
Associated companies
Transaction History
| INGR | ▼ Sell | Open Market | 375 | $42K | 3/18/2026 | View on chart |
| INGR | ▲ Buy | Grant | 1,733 | $193K | 3/12/2026 | View on chart |
| INGR | ▲ Buy | Grant | 976 | $115K | 2/25/2026 | View on chart |
| INGR | ▼ Sell | Tax Withholding | 181 | $21K | 2/17/2026 | View on chart |
| INGR | ▲ Buy | Grant | 1,962 | $0 | 2/9/2026 | View on chart |
| INGR | ▼ Sell | Tax Withholding | 646 | $77K | 2/9/2026 | View on chart |
| INGR | ▲ Buy | Grant | 443 | $58K | 2/26/2025 | View on chart |
| INGR | ▼ Sell | Tax Withholding | 184 | $23K | 2/16/2025 | View on chart |
| INGR | ▼ Sell | Tax Withholding | 728 | $94K | 2/11/2025 | View on chart |
| INGR | ▲ Buy | Grant | 2,302 | $0 | 2/11/2025 | View on chart |
| INGR | ▲ Buy | Option Exercise | 1,163 | $103K | 3/1/2024 | View on chart |
| INGR | ▲ Buy | Option Exercise | 805 | $79K | 3/1/2024 | View on chart |
| INGR | ▼ Sell | Open Market | 1,968 | $231K | 3/1/2024 | View on chart |
| INGR | ▲ Buy | Grant | 526 | $57K | 2/13/2024 | View on chart |
| INGR | ▲ Buy | Option Exercise | 1,164 | $103K | 5/24/2023 | View on chart |
| INGR | ▼ Sell | Open Market | 1,164 | $128K | 5/24/2023 | View on chart |
| INGR | ▲ Buy | Grant | 569 | $56K | 2/15/2023 | View on chart |
| INGR | ▲ Buy | Grant | 576 | $51K | 2/16/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Ingredion Sees Rising Clean-Label Demand, UBS Lowers Target
Demand for clean‑label ingredients is growing, which has helped lift Ingredion’s share price. UBS kept a neutral stance but cut its price target to $104, citing uncertainty about future momentum. The company’s T&HS solutions are being examined for their ability to sustain growth into 2026.
Ingredion Sees Rising Clean-Label Demand, UBS Lowers Target. Demand for clean‑label ingredients is growing, which has helped lift Ingredion’s share price. UBS kept a neutral stance but cut its price target to $104, citing uncertainty about future momentum. The company’s T&HS solutions are being examined for their ability to sustain growth into 2026.